Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Engelman

Showing results (221-230 of 238) with videos related to

Pageof 24
Sort By:
Nature Communications|December 10, 2020
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblastsAngelo L Grauel, Beverly Nguyen, David Ruddy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2017
Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIMKyung-A Song, Matthew J Niederst, Timothy L Lochmann, et al.
Cancer Research Communications|November 1, 2024
Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic CancerSlavica Dimitrieva, Jon M Harrison, Jonathan Chang, et al.
Nature Genetics|August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Claire A Margolis, Natalie I Vokes, et al.
Cancer Discovery|January 22, 2014
Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuitZehua Zhu, Amir R Aref, Travis J Cohoon, et al.
Science Translational Medicine|May 26, 2017
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activationDavid P Kodack, Vasileios Askoxylakis, Gino B Ferraro, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancerAnthony C Faber, Anna F Farago, Carlotta Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2011
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practiceL V Sequist, R S Heist, A T Shaw, et al.
Cancer Cell|February 10, 2016
Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationJungoh Ham, Carlotta Costa, Renata Sano, et al.
The New England Journal of Medicine|October 29, 2010
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancerEunice L Kwak, Yung-Jue Bang, D Ross Camidge, et al.
Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
Nature Communications|December 10, 2020
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblastsAngelo L Grauel, Beverly Nguyen, David Ruddy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2017
Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIMKyung-A Song, Matthew J Niederst, Timothy L Lochmann, et al.
Cancer Research Communications|November 1, 2024
Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic CancerSlavica Dimitrieva, Jon M Harrison, Jonathan Chang, et al.
Nature Genetics|August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Claire A Margolis, Natalie I Vokes, et al.
Cancer Discovery|January 22, 2014
Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuitZehua Zhu, Amir R Aref, Travis J Cohoon, et al.
Science Translational Medicine|May 26, 2017
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activationDavid P Kodack, Vasileios Askoxylakis, Gino B Ferraro, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancerAnthony C Faber, Anna F Farago, Carlotta Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2011
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practiceL V Sequist, R S Heist, A T Shaw, et al.
Cancer Cell|February 10, 2016
Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationJungoh Ham, Carlotta Costa, Renata Sano, et al.
The New England Journal of Medicine|October 29, 2010
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancerEunice L Kwak, Yung-Jue Bang, D Ross Camidge, et al.
Pageof 24